Staff Publications: December 2018

  1. Al-Hebshi NN, Nasher AT, Maryoud MY, et al. Inflammatory Bacteriome Featuring Fusobacterium Nucleatum and Pseudomonas Aeruginosa Identified in Association with Oral Squamous Cell Carcinoma. Sci Rep. 2017;7(1):1834. PMID: 28500338. PMC5431832.
  2. Bai T, Chanda AK, Egleston BL, Vucetic S. EHR Phenotyping via Jointly Embedding Medical Concepts and Words into a Unified Vector Space. BMC Med Inform Decis Mak. 2018;18(Suppl 4):123. PMID: 30537974. PMC6290514.
  3. Bair SM, Strelec LE, Feldman TA, et al. Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis. Oncologist. 2018. PMID: 30568021.
  4. Bergman A, Gligorijevic B. Real-Time Imaging of Invadopodia in Tumor Microenvironment Context. (2018) Optics InfoBase Conference Papers, Part F89-MICROSCOPY 2 p.
  5. Cheson BD, O’Brien S, Ewer MS, et al. Optimal Management of Adverse Events from Copanlisib in the Treatment of Patients with Non-Hodgkin Lymphomas. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30584024.
  6. Correa AF, Yankey H, Li T, et al. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019;123:174-180. PMID: 30296503.
  7. de Prisco N, Stout E, Font-Burgada J. Specific Labeling and Lineage Tracing of Periportal Hepatocytes Using Two-Step Genetic Recombination. Methods Mol Biol. 2019;1905:59-70. PMID: 30536090.
  8. Dignam JJ, Hamstra DA, Lepor H, et al. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2018:JCO1800154. PMID: 30526194.
  9. Dyer KE, Shires DA, Flocke SA, et al. Patient-Reported Needs Following a Referral for Colorectal Cancer Screening. Am J Prev Med. 2018. PMID: 30554975.
  10. Edwards DC, Cahn DB, Reddy M, et al. Incisional Hernia after Cystectomy: Incidence, Risk Factors and Anthropometric Predisposition. Can J Urol. 2018;25(6):9573-9578. PMID: 30553281.
  11. Ghatalia P, Zibelman MR, Geynisman DM, Plimack ER. Evolving Landscape of the Treatment of Metastatic Clear Cell Renal Cell Carcinoma. Clin Adv Hematol Oncol. 2018;16(10):677-686. PMID: 30543598.
  12. Gotlib J, Gerds AT, Bose P, et al. Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(12):1500-1537. PMID: 30545997.
  13. Gounder MM, Mahoney MR, Van Tine BA, et al. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med. 2018;379(25):2417-2428. PMID: 30575484.
  14. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593. PMC6065537.
  15. Haddad RI, Nasr C, Bischoff L, et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. J Natl Compr Canc Netw. 2018;16(12):1429-1440. PMID: 30545990.
  16. Hendifar AE, Petzel MQB, Zimmers TA, et al. Pancreas Cancer-Associated Weight Loss. Oncologist. 2018. PMID: 30591550.
  17. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  18. Heyza JR, Arora S, Zhang H, et al. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells. Nutrients. 2018;10(11). PMID: 30400270. PMC6267282.
  19. Ito T, Derweesh IH, Ginzburg S, et al. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017;197(1):31-36. PMID: 27418453.
  20. Jones CE, Hammer AM, Cho Y, et al. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia. 2019;21(1):132-145. PMID: 30550871. PMC6293034.
  21. Kasagi Y, Dods K, Wang JX, et al. Fibrostenotic Eosinophilic Esophagitis May Reflect Epithelial Lysyl Oxidase Induction by Fibroblasts-Derived Tumor Necrosis Factor-Alpha. J Allergy Clin Immunol. 2018. PMID: 30578874.
  22. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880.
  23. Kozlova AL, Valieva ME, Maluchenko NV, Studitsky VM. HMGB Proteins as DNA Chaperones That Modulate Chromatin Activity. Molecular Biology. 2018;52(5):637-647.
  24. Liao L, Alicea-Velazquez NL, Langbein L, et al. High Affinity Binding of H3K14AC through Collaboration of Bromodomains 2, 4, and 5 is Critical for the Molecular and Tumor Suppressor Functions of PBRM1. Mol Oncol. 2018. PMID: 30585695.
  25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an IMRT Patient on a Second Accelerator without Replanning? Med Dosim. 2018;43(4):334-343. PMID: 29287919.
  26. Liu B, Tang L, Zhang X, et al. A Cell-Based High Throughput Screening Assay for the Discovery of CGAS-STING Pathway Agonists. Antiviral Res. 2017;147:37-46. PMID: 28982551. PMC5789800. NIHMS911402.
  27. Lu H, Liu S, Zhang G, et al. Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-Mutant Melanomas. Nature. 2019;565(7738):E4. PMID: 30532003.
  28. MacFawn I, Wilson H, Selth LA, et al. Grainyhead-Like-2 Confers NK-Sensitivity through Interactions with Epigenetic Modifiers. Mol Immunol. 2018;105:137-149. PMID: 30508726.
  29. Magnius L, Taylor J, Mason WS, et al. ICTV Virus Taxonomy Profile: Deltavirus. J Gen Virol. 2018;99(12):1565-1566. PMID: 30311870.
  30. Martin JM, Wu H, Barta SK. Cd30+ T-Cell Lymphoproliferative Disorders. Chin Clin Oncol. 2018. PMID: 30525751.
  31. Mavaddat N, Michailidou K, Dennis J, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am J Hum Genet. 2019;104(1):21-34. PMID: 30554720.
  32. Ming M, Wu W, Xie B, et al. XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Mol Cancer Ther. 2018;17(12):2564-2574. PMID: 3051014.
  33. Mortazavi SAR, Kadivar F, Mortazavi SMJ. Comments on, “A Narrative Review of Interventions for Improving Sleep and Reducing Circadian Disruption in Medical Inpatients”. Sleep Med. 2018. PMID: 30503687.
  34. Parham LR, Williams PA, Chatterji P, Whelan KA, Hamilton KE. RNA Regulons Are Essential in Intestinal Homeostasis. Am J Physiol Gastrointest Liver Physiol. 2019;316(1):G197-G204. PMID: 30520692.
  35. Pourfarhangi KE, Bayarmagnai B, de la Hoz EC, Cohen A, Gligorijevic B. A Methodology to Investigate the Relationship between Cancer Cells Cell-Cycle Phase and Their Migratory Behaviors. Optics InfoBase Conference Papers, Part F91-TRANSLATIONAL. 2 p. 2018.
  36. Prabhu VV, Madhukar NS, Gilvary C, et al. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2018. PMID: 30559168.
  37. Ramos JD, Wingate JT, Gulati R, et al. Venous Thromboembolism Risk in Patients with Locoregional Urothelial Tract Tumors. Clin Genitourin Cancer. 2017;16(1):e161-e167. PMID: 28923700. PMC5826750.
  38. Redner RL, Beumer JH, Kropf P, et al. A Phase-1 Study of Dasatinib plus All-Trans Retinoic Acid in Acute Myeloid Leukemia. Leuk Lymphoma. 2018;59(11):2595-2601. PMID: 29616864. PMC6201295.
  39. Reese JB, Smith KC, Handorf E, et al. A Randomized Pilot Trial of a Couple-Based Intervention Addressing Sexual Concerns for Breast Cancer Survivors. J Psychosoc Oncol. 2018:1-22. PMID: 30580675.
  40. Reese JB, Sorice KA, Oppenheimer NM, et al. Why Do Breast Cancer Survivors Decline a Couple-Based Intimacy Enhancement Intervention Trial? Transl Behav Med. 2018. PMID: 30544201.
  41. Roethke SK, Ryan JC, Wood SY. Management of Older Patients with Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. J Adv Pract Oncol. 2018;9(1):67-76. PMID: 30564469. PMC6296420.
  42. Roussi P, Miller SM, Giri VN, et al. Effects of a Randomized Trial Comparing Standard and Enhanced Counseling for Men at High Risk of Prostate Cancer as a Function of Race and Monitoring Style. J Health Psychol. 2016;23(14):1359105316671188. PMID: 28810355. PMC5561513.
  43. Shulman RM, Meyer JE, Li T, Howell KJ. External Beam Radiation Therapy (EBRT) for Asymptomatic Bone Metastases in Patients with Solid Tumors Reduces the Risk of Skeletal-Related Events (SRES). Ann Palliat Med. 2018. PMID: 30525770.
  44. Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic Reprogramming of Epithelial Mesenchymal Transition in Triple Negative Breast Cancer Cells with DNA Methyltransferase and Histone Deacetylase Inhibitors. J Exp Clin Cancer Res. 2018;37(1):314. PMID: 30547810. PMC6295063.
  45. Walpole S, Pritchard AL, Cebulla CM, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328-1341. PMID: 30517737. PMC6292796.
  46. White MN, Dotan E, Catalano PJ, Cardin DB, Berlin JD. Advanced Pancreatic Cancer Clinical Trials: The Continued Underrepresentation of Older Patients. J Geriatr Oncol. 2018. PMID: 30573201.
  47. Wickersham KE, Hodges TK, Edelman MJ, Song Y, Nan M, Dorsey SG. Differential Gene Expression in Erlotinib-Treated Fibroblasts. Nurs Res. 2018. PMID: 30540703.
  48. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
  49. Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE. Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis. Am J Clin Oncol. 2019;42(1):46-55. PMID: 29965809.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s